Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19
Saved in:
Main Author: | Abdolkarim Mahrooz |
---|---|
Format: | article |
Language: | EN |
Published: |
Wolters Kluwer Medknow Publications
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/ab16a58aeeeb4dcba6f3a950d6bb94b1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperosmolarity Deserves More Attention in Critically Ill COVID-19 Patients with Diabetes: A Cohort-Based Study
by: Gou L, et al.
Published: (2021) -
Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
by: Marcela Doktorova, et al.
Published: (2017) -
ABCC6 deficiency promotes dyslipidemia and atherosclerosis
by: Christopher Brampton, et al.
Published: (2021) -
Maternal obesity in Africa: Is it time to pay more attention?
by: O.J. Onubi, et al.
Published: (2015) -
TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis
by: Daniel Zysset, et al.
Published: (2016)